Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07817225
What this trial is testing

Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation

Who this might be right for
Pancreatic Neuroendocrine Tumor
Massimo Falconi 30
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Not applicableStudy completedNCT04984174
What this trial is testing

Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 14,760
Not applicableUnknownNCT04687410
What this trial is testing

Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs

Who this might be right for
Pancreas NeoplasmPancreas Cancer
Peter Vilmann MD, DSc, HC, FASGE 68
Not applicableLooking for participantsNCT06939023
What this trial is testing

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

Who this might be right for
PancreatectomyDistal Pancreatectomy (DP)Pancreatic Neoplasms+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 256
Not applicableActive Not RecruitingNCT04247503
What this trial is testing

Cohort Study of Pancreatic Cancer Risk

Who this might be right for
Familial Pancreatic Cancer
Mayo Clinic 419
Testing effectiveness (Phase 2)Ended earlyNCT00683085
What this trial is testing

Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreas Neoplasms
Tokyo University 2
Not applicableNot Yet RecruitingNCT06528223
What this trial is testing

Research of the Application of Artificial Intelligence Model "PANDA"

Who this might be right for
Pancreatic Cancer
Zhejiang University 200,000
Testing effectiveness (Phase 2)Study completedNCT01078662
What this trial is testing

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Who this might be right for
OvarianBreastProstate+2 more
AstraZeneca 298
Not applicableActive Not RecruitingNCT04246203
What this trial is testing

Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Ludwig-Maximilians - University of Munich 200
Testing effectiveness (Phase 2)Looking for participantsNCT05040360
What this trial is testing

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8+2 more
SWOG Cancer Research Network 141
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Large-scale testing (Phase 3)Study completedNCT00510068
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Advanced Neuroendocrine Tumors of Pancreatic Origin
Novartis Pharmaceuticals 410
Testing effectiveness (Phase 2)Looking for participantsNCT07101679
What this trial is testing

GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma
West China Hospital 23
Not applicableStudy completedNCT05162846
What this trial is testing

Michigan Genetic Hereditary Testing (MiGHT)

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+4 more
University of Michigan Rogel Cancer Center 793
Not applicableStudy completedNCT00900003
What this trial is testing

Studying Biomarkers in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Vanderbilt-Ingram Cancer Center 53
Early research (Phase 1)Study completedNCT00252889
What this trial is testing

Doxil Topotecan Doublet Cancer Study

Who this might be right for
Small Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more
Christiana Care Health Services 20
Large-scale testing (Phase 3)Study completedNCT05074589
What this trial is testing

Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Who this might be right for
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
Jiangsu HengRui Medicine Co., Ltd. 298
Testing effectiveness (Phase 2)Study completedNCT02628860
What this trial is testing

Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy

Who this might be right for
Pancreatic CancerAnemia
National Cancer Center, Korea 40
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Next Page